Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Transdermal Delivery of Ketorolac Tromethamine Using Microemulsion Vehicles

Anayatollah Salimi 1 , 2 , * , Shadi Jafarinezhad 2 and Azin Kalantari 3
Authors Information
1 Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Pharmaceutics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of Pharmaceutical Technology, University of Debrecen, Debrecen, Hungary
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: 13 (4); e69056
  • Published Online: December 1, 2018
  • Article Type: Research Article
  • Received: April 7, 2018
  • Revised: May 5, 2018
  • Accepted: May 12, 2018
  • DOI: 10.5812/jjnpp.69056

To Cite: Salimi A, Jafarinezhad S, Kalantari A. Transdermal Delivery of Ketorolac Tromethamine Using Microemulsion Vehicles, Jundishapur J Nat Pharm Prod. Online ahead of Print ; 13(4):e69056. doi: 10.5812/jjnpp.69056.

Abstract
Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kim BY, Doh HJ, Le TN, Cho WJ, Yong CS, Choi HG, et al. Ketorolac amide prodrugs for transdermal delivery: Stability and in vitro rat skin permeation studies. Int J Pharm. 2005;293(1-2):193-202. doi: 10.1016/j.ijpharm.2005.01.002. [PubMed: 15778057].
  • 2. Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm. 2001;51(2):135-42. [PubMed: 11226820].
  • 3. Essa EA, Bonner MC, Barry BW. Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid. J Control Release. 2003;92(1-2):163-72. [PubMed: 14499194].
  • 4. Salimi A, Hedayatipour N, Moghimipour E. The effect of various vehicles on the naproxen permeability through rat skin: A mechanistic study by DSC and FT-IR techniques. Adv Pharm Bull. 2016;6(1):9-16. doi: 10.15171/apb.2016.003. [PubMed: 27099831]. [PubMed Central: PMC4833885].
  • 5. Moghimipour E, Salimi A, Sharif Makhmal Zadeh B. Effect of the various solvents on the in vitro permeability of vitamin B 12 through excised rat skin. Trop J Pharm Res. 2013;12(5):671-7. doi: 10.4314/tjpr.v12i5.2.
  • 6. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev. 2002;54 Suppl 1:S77-98. [PubMed: 12460717].
  • 7. Heuschkel S, Goebel A, Neubert RH. Microemulsions--modern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci. 2008;97(2):603-31. doi: 10.1002/jps.20995. [PubMed: 17696162].
  • 8. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001;52(2):103-12. doi: 10.1016/S0939-6411(01)00166-7. [PubMed: 11522474].
  • 9. Salimi A, Sharif Makhmal Zadeh B, Moghimipour E. Preparation and characterization of cyanocobalamin (vit B12) microemulsion properties and structure for topical and transdermal application. Iran J Basic Med Sci. 2013;16(7):865-72. [PubMed: 23997918]. [PubMed Central: PMC3758059].
  • 10. Moghimipour E, Salimi A, Changizi S. Preparation and microstructural characterization of griseofulvin microemulsions using different experimental methods: SAXS and DSC. Adv Pharm Bull. 2017;7(2):281-9. doi: 10.15171/apb.2017.034. [PubMed: 28761831]. [PubMed Central: PMC5527243].
  • 11. Zhang J, Michniak-Kohn B. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: Ketoprofen, lidocaine, and caffeine. Int J Pharm. 2011;421(1):34-44. doi: 10.1016/j.ijpharm.2011.09.014. [PubMed: 21959104].
  • 12. Moghimipour E, Salimi A, Leis F. Preparation and evaluation of tretinoin microemulsion based on pseudo-ternary phase diagram. Adv Pharm Bull. 2012;2(2):141-7. doi: 10.5681/apb.2012.022. [PubMed: 24312785]. [PubMed Central: PMC3845984].
  • 13. Salimi A, Sharif Makhmal Zadeh B, Hemati AA, Akbari Birgani S. Design and evaluation of self-emulsifying drug delivery system (SEDDS) of carvedilol to improve the oral absorption. Jundishapur J Nat Pharm Prod. 2014;9(3). e16125. [PubMed: 25237644]. [PubMed Central: PMC4165178].
  • 14. Kalantari A, Kosa D, Nemes D, Ujhelyi Z, Feher P, Vecsernyes M, et al. Self-nanoemulsifying drug delivery systems containing plantago lanceolata-an assessment of their antioxidant and antiinflammatory effects. Molecules. 2017;22(10). doi: 10.3390/molecules22101773. [PubMed: 29053620]. [PubMed Central: PMC6151772].
  • 15. Rahdar A, Almasi-Kashi M, Muhammad Khan A, Aliahmad M, Salimi A, Guettari M, et al. Effect of ion exchange in NaAOT surfactant on droplet size and location of dye within Rhodamine B (RhB)-containing microemulsion at low dye concentration. J Mol Liq. 2018;252:506-13. doi: 10.1016/j.molliq.2018.01.004.
  • 16. Moghimipour E, Salimi A, Karami M, Isazadeh S. Preparation and characterization of dexamethasone microemulsion based on pseudoternary phase diagram. Jundishapur J Nat Pharm Prod. 2013;8(3):105-12. [PubMed: 24624198]. [PubMed Central: PMC3941903].
  • 17. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2-3):165-96. [PubMed: 11311991].
  • 18. Garti N, Aserin A, Tiunova I, Fanun M. A DSC study of water behavior in water-in-oil microemulsions stabilized by sucrose esters and butanol. Colloids Surf. 2000;170(1):1-18. doi: 10.1016/S0927-7757(00)00486-6.
  • 19. Podlogar F, Gasperlin M, Tomsic M, Jamnik A, Rogac MB. Structural characterisation of water-Tween 40/Imwitor 308-isopropyl myristate microemulsions using different experimental methods. Int J Pharm. 2004;276(1-2):115-28. doi: 10.1016/j.ijpharm.2004.02.018. [PubMed: 15113620].
  • 20. Moghimipour E, Salimi A, Eftekhari S. Design and characterization of microemulsion systems for naproxen. Adv Pharm Bull. 2013;3(1):63-71. doi: 10.5681/apb.2013.011. [PubMed: 24312814]. [PubMed Central: PMC3846048].
  • 21. Naveh N, Weissman C, Muchtar S, Benita S, Mechoulam R. A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits. Graefes Arch Clin Exp Ophthalmol. 2000;238(4):334-8. [PubMed: 10853933].
  • 22. Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009;1788(11):2362-73. doi: 10.1016/j.bbamem.2009.08.015. [PubMed: 19733150].
  • 23. Salimi A. Enhanced stability and dermal delivery of hydroquinone using microemulsion-based system. Asian J Pharm (AJP). 2017;11(4):773-81. doi: 10.22377/ajp.v11i04.1714.
  • 24. Sarpotdar PP, Zatz JL. Percutaneous absorption enhancement by nonionic surfactants. Drug Dev Ind Pharm. 1986;12(11-13):1625-47.
  • 25. Kajbafvala A, Salabat A, Salimi A. Formulation, characterization, and in vitro/ex vivo evaluation of quercetin-loaded microemulsion for topical application. Pharm Dev Technol. 2018;23(8):741-50. doi: 10.1080/10837450.2016.1263995. [PubMed: 27871215].
  • 26. Goodman M, Barry BW. Lipid-protein-partitioning theory of skin penetration enhancement. Int J Pharm. 1989;57:29-40. doi: 10.1016/0378-5173(89)90260-3.
  • 27. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603-18. doi: 10.1016/j.addr.2003.10.025. [PubMed: 15019749].
  • 28. Lopes LB. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics. 2014;6(1):52-77. doi: 10.3390/pharmaceutics6010052. [PubMed: 24590260]. [PubMed Central: PMC3978525].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments